649 related articles for article (PubMed ID: 11304876)
21. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
22. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
[TBL] [Abstract][Full Text] [Related]
23. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
24. Physiologic aspects of natural and surgical menopause.
Bachmann G
J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
[TBL] [Abstract][Full Text] [Related]
25. Androgens and breast cancer.
Kotsopoulos J; Narod SA
Steroids; 2012 Jan; 77(1-2):1-9. PubMed ID: 22015396
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
27. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.
Raisz LG; Wiita B; Artis A; Bowen A; Schwartz S; Trahiotis M; Shoukri K; Smith J
J Clin Endocrinol Metab; 1996 Jan; 81(1):37-43. PubMed ID: 8550780
[TBL] [Abstract][Full Text] [Related]
29. Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996.
Gelfand MM; Wiita B
Clin Ther; 1997; 19(3):383-404; discussion 367-8. PubMed ID: 9220205
[TBL] [Abstract][Full Text] [Related]
30. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
31. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
[TBL] [Abstract][Full Text] [Related]
32. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
33. Safety of testosterone use in women.
Shufelt CL; Braunstein GD
Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
[TBL] [Abstract][Full Text] [Related]
34. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
36. Psychosexual effects of menopause: role of androgens.
Sarrel PM
Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S319-24. PubMed ID: 10076172
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer risk in testosterone-treated men.
Raynaud JP
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
[TBL] [Abstract][Full Text] [Related]
38. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
[TBL] [Abstract][Full Text] [Related]
39. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
40. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
